In last trading session, Bausch Health Companies Inc. (NYSE:BHC) saw 4,442,875 shares changing hands with its beta currently measuring 1.23. Company’s recent per share price level of $17.39 trading at -$0.27 or -1.53% at ring of the bell on the day assigns it a market valuation of $6.15 Billion. That closing price of BHC’s stock is at a discount of -83.84% from its 52-week high price of $31.97 and is indicating a premium of 35.88% from its 52-week low price of $11.15. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.95 Million shares which gives us an average trading volume of 4.83 Million if we extend that period to 3-months.
For Bausch Health Companies Inc. (BHC), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2.2. Splitting up the data highlights that, out of 18 analysts covering the stock, none rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 10 see the stock as a Buy. 1 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0.95 in the current quarter.
Bausch Health Companies Inc. (NYSE:BHC) trade information
In the face of being in the red today for losing -1.53%, in the last five days BHC remained trading in the green while hitting it’s week-highest on Thursday, Aug 06 when the stock touched $22.97- price level, adding 24.29% to its value on the day. Bausch Health Companies Inc.’s shares saw a change of -41.88% in year-to-date performance and have moved -10.64% in past 5-day. Bausch Health Companies Inc. (NYSE:BHC) showed a performance of 1.16% in past 30-days. Number of shares sold short was 17.23 Million shares which calculate 3.57 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $28 to the stock, which implies a rise of 61.01% to its current value. Analysts have been projecting $16 as a low price target for the stock while placing it at a high target of $64. It follows that stock’s current price would jump +268.03% in reaching the projected high whereas dropping to the targeted low would mean a loss of -7.99% for stock’s current value.
Bausch Health Companies Inc. (BHC) estimates and forecasts
Statistics highlight that Bausch Health Companies Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lessened -39.09% of value to its shares in past 6 months, showing an annual growth rate of -15.12% while that of industry is -8.3. Apart from that, the company came lowering its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to decline by -20.2% in the current quarter and calculating 12.5% increase in the next quarter. This year revenue growth is estimated to drop -8.1% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $1.99 Billion for the same. And 13 analysts are in estimates of company making revenue of $2.2 Billion in the next quarter that will end in December 01, 2020. Company posted $2.21 Billion and $2.22 Billion of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to drop by -10.1% while estimating it to be -1.1% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -31.7% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 57% while estimates for its earnings growth in next 5 years are of 2%
Bausch Health Companies Inc. (NYSE:BHC)’s Major holders
Insiders are in possession of 0.55% of company’s total shares while institution are holding 66.95% percent of that, with stock having share float percentage of 67.32%. Investors also watch the number of corporate investors in a company very closely, which is 519 institutions for Bausch Health Companies Inc. that are currently holding shares of the company. FIL LTD is the top institutional holder at BHC for having 33.48 Million shares of worth $518.88 Million. And as of March 30, 2020, it was holding 9.43% of the company’s outstanding shares.
The second largest institutional holder is Paulson & Company, Inc., which was holding about 20.84 Million shares on March 30, 2020. The number of shares represents firm’s hold over 5.87% of outstanding shares, having a total worth of $323.01 Million.
On the other hand, Vanguard International Stock Index-Total Intl Stock Indx and Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund are the top two Mutual Funds which own company’s shares. As of April 29, 2020, the former fund manager was holding 6031282 shares of worth $109.29 Million or 1.7% of the total outstanding shares. The later fund manager was in possession of 2.23 Million shares on March 30, 2020, making its stake of worth around $34.51 Million in the company or a holder of 0.63% of company’s stock.